Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Feb 27, 2024 |
amended on third reading 1159b |
Feb 12, 2024 |
advanced to third reading |
Feb 07, 2024 |
2nd report cal. |
Feb 06, 2024 |
1st report cal.381 |
Feb 01, 2024 |
print number 1159a |
Feb 01, 2024 |
amend (t) and recommit to health |
Jan 03, 2024 |
referred to health |
Jun 10, 2023 |
committed to rules |
Feb 06, 2023 |
advanced to third reading |
Feb 01, 2023 |
2nd report cal. |
Jan 31, 2023 |
1st report cal.244 |
Jan 10, 2023 |
referred to health |
Senate Bill S1159B
2023-2024 Legislative Session
Sponsored By
(D) 42nd Senate District
Current Bill Status - On Floor Calendar
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
Bill Amendments
co-Sponsors
(D) 6th Senate District
(D, WF) 52nd Senate District
2023-S1159 - Details
2023-S1159 - Summary
Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
2023-S1159 - Sponsor Memo
BILL NUMBER: S1159 SPONSOR: SKOUFIS TITLE OF BILL: An act to amend the public health law, in relation to requiring a writ- ten notice on the occurrence of a false-positive result for any condi- tion tested during a prenatal test PURPOSE: Requires a written notice on the occurrence of a false-positive result for any condition tested during a prenatal test. SUMMARY OF PROVISIONS: Section 1: Amends the public health law by adding a new section 2533, which requires that every prenatal test must include a written notice of the occurrence of false-positive results for any condition tested, provided by the entity that created the test or advertises performing prenatal testing services. The written notice must be provided to the patient or potential parent prior to any prenatal test, with the test
2023-S1159 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 1159 2023-2024 Regular Sessions I N S E N A T E January 10, 2023 ___________ Introduced by Sens. SKOUFIS, THOMAS -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to requiring a writ- ten notice on the occurrence of a false-positive result for any condi- tion tested during a prenatal test THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 2533 to read as follows: § 2533. DISCLOSURE OF INFORMATION CONCERNING PRENATAL TESTING. A. THE FOLLOWING TERMS AS USED IN THIS SECTION SHALL MEAN THE FOLLOWING: 1. "LABORATORY" SHALL HAVE THE SAME MEANING AS IS SET FORTH IN SECTION FIVE HUNDRED SEVENTY-ONE OF THIS CHAPTER. 2. "PRENATAL TESTING SERVICES" MEANS ANY SERVICE PROVIDED BY A HOSPI- TAL TO IDENTIFY POTENTIAL PROBLEMS WITH A PREGNANCY OR THE RELATIVE LIKELIHOOD OF ABNORMALITIES IN A FETUS. SUCH SERVICES SHALL INCLUDE BUT NOT BE LIMITED TO SERVICES THAT TEST PLACENTAL TISSUE OR THE BLOOD OF A PREGNANT PATIENT. 3. "MATERIAL" MEANS ANY ADVERTISEMENT, PROMOTIONAL BROCHURE, WEBSITE OR DOCUMENTATION THAT MAY BE PRESENTED TO A PATIENT OR A POTENTIAL PARENT TO RECOMMEND PRENATAL TESTING SERVICES OFFERED BY A HOSPITAL. 4. "PERCENTAGE OF POSITIVES BEING A FALSE-POSITIVE" MEANS THE RATIO OF THE NUMBER OF FALSE-POSITIVE RESULTS DIVIDED BY THE SUM OF THE NUMBER OF FALSE-POSITIVE RESULTS AND THE NUMBER OF TRUE POSITIVES. B. EVERY PRENATAL TEST SHALL INCLUDE A WRITTEN NOTICE, PROVIDED BY THE ENTITY WHICH MANUFACTURED, SUPPLIED, OR OTHERWISE CREATED SUCH TEST OR WHICH ADVERTISED PERFORMING PRENATAL TESTS, ABOUT THE OCCURRENCE OF A FALSE-POSITIVE RESULT, INCLUDING BUT NOT LIMITED TO THE PERCENTAGE OF POSITIVES BEING A FALSE-POSITIVE, FOR ANY CONDITION TESTED DURING SUCH PRENATAL TEST. SUCH WRITTEN NOTICE SHALL BE PROVIDED TO A PATIENT OR A POTENTIAL PARENT: (I) PRIOR TO ANY PRENATAL TEST; (II) WITH SUCH TEST EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD04085-01-3
co-Sponsors
(D) 6th Senate District
(D, WF) 52nd Senate District
2023-S1159A - Details
2023-S1159A - Summary
Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
2023-S1159A - Sponsor Memo
BILL NUMBER: S1159A SPONSOR: SKOUFIS TITLE OF BILL: An act to amend the public health law, in relation to requiring disclo- sure of information concerning non-invasive prenatal screening for chro- mosomal abnormalities PURPOSE: Requires that entities resting providing non-invasive prenatal screening for chromosomal abnormalities disclose information about the screening and what the results could mean to patients SUMMARY OF PROVISIONS: Section 1: Amends the public health law by adding a new section 2533, requiring a disclosure of information regarding non-invasive prenatal screening for chromosomal abnormalities. It provides definitions for terms, such as "laboratory" and "non-invasive prenatal screening." States that Non-invasive prenatal screenings must be accompanied by a
2023-S1159A - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 1159--A 2023-2024 Regular Sessions I N S E N A T E January 10, 2023 ___________ Introduced by Sens. SKOUFIS, THOMAS, WEBB -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- recommitted to the Committee on Health in accordance with Senate Rule 6, sec. 8 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to requiring disclo- sure of information concerning non-invasive prenatal screening for chromosomal abnormalities THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 2533 to read as follows: § 2533. DISCLOSURE OF INFORMATION CONCERNING NON-INVASIVE PRENATAL SCREENING FOR CHROMOSOMAL ABNORMALITIES. 1. FOR THE PURPOSES OF THIS SECTION, THE FOLLOWING TERMS SHALL MEAN THE FOLLOWING: (A) "LABORATORY" SHALL HAVE THE SAME MEANING AS IS SET FORTH IN SECTION FIVE HUNDRED SEVENTY-ONE OF THIS CHAPTER. (B) "NON-INVASIVE PRENATAL SCREENING" SHALL MEAN ANY NON-INVASIVE PRENATAL SCREENING OR CELL FREE FETAL DNA SCREENING USED TO ASCERTAIN WHETHER A FETUS IS AT RISK FOR CERTAIN CHROMOSOMAL ABNORMALITIES. 2. NON-INVASIVE PRENATAL SCREENINGS SHALL BE ACCOMPANIED BY A WRITTEN NOTICE, PROVIDED BY THE ENTITY WHICH MANUFACTURED, SUPPLIED, OR OTHER- WISE CREATED SUCH TEST OR WHICH ADVERTISED PERFORMING THESE PRENATAL SCREENING TESTS, ABOUT THE USE OF SUCH TEST FOR SCREENING PURPOSES, THE FACT THAT NOT ALL HIGH RISK OCCURRENCES CORRESPOND TO A POSITIVE RESULT, THE FACT THAT NOT ALL LOW RISK RESULTS CORRESPOND TO A NEGATIVE RESULT, A CLEAR STATEMENT INDICATING THAT NON-INVASIVE PRENATAL SCREENINGS ARE INTENDED SOLELY FOR SCREENING PURPOSES TO ASSESS RISK OF POSSIBLE FETAL GENETIC ABNORMALITIES AND IS NOT INTENDED TO BE USED FOR DIAGNOSTIC PURPOSES TO DETERMINE WHETHER SUCH ABNORMALITIES ACTUALLY EXIST AND THAT ANY POSITIVE RESULT SHOULD BE FOLLOWED BY CONFIRMATORY DIAGNOSTIC TEST- EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD04085-02-4
co-Sponsors
(D) 6th Senate District
(D, WF) 52nd Senate District
2023-S1159B (ACTIVE) - Details
2023-S1159B (ACTIVE) - Summary
Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
2023-S1159B (ACTIVE) - Sponsor Memo
BILL NUMBER: S1159B SPONSOR: SKOUFIS TITLE OF BILL: An act to amend the public health law, in relation to requiring disclo- sure of information concerning non-invasive prenatal screening for chro- mosomal abnormalities PURPOSE: Requires that entities resting providing non-invasive prenatal screening for chromosomal abnormalities disclose information about the screening and what the results could mean to patients SUMMARY OF PROVISIONS: Section 1: Amends the public health law by adding a new section 2533, requiring a disclosure of information regarding non-invasive prenatal screening for chromosomal abnormalities. It provides definitions for terms such as "non-invasive prenatal screening." States that Non-inva- sive prenatal screenings must be accompanied by a written notice,
2023-S1159B (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 1159--B Cal. No. 381 2023-2024 Regular Sessions I N S E N A T E January 10, 2023 ___________ Introduced by Sens. SKOUFIS, THOMAS, WEBB -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- recommitted to the Committee on Health in accordance with Senate Rule 6, sec. 8 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- reported favorably from said committee, ordered to first and second report, ordered to a third reading, amended and ordered reprinted, retaining its place in the order of third reading AN ACT to amend the public health law, in relation to requiring disclo- sure of information concerning non-invasive prenatal screening for chromosomal abnormalities THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 2533 to read as follows: § 2533. DISCLOSURE OF INFORMATION CONCERNING NON-INVASIVE PRENATAL SCREENING FOR CHROMOSOMAL ABNORMALITIES. 1. FOR THE PURPOSES OF THIS SECTION, THE TERM "NON-INVASIVE PRENATAL SCREENING" SHALL MEAN ANY NON- INVASIVE PRENATAL SCREENING OR CELL FREE FETAL DNA SCREENING USED TO ASCERTAIN WHETHER A FETUS IS AT RISK FOR CERTAIN CHROMOSOMAL ABNOR- MALITIES. 2. NON-INVASIVE PRENATAL SCREENINGS SHALL BE ACCOMPANIED BY A WRITTEN NOTICE, PROVIDED BY THE ENTITY WHICH MANUFACTURED, SUPPLIED, OR OTHER- WISE CREATED SUCH TEST OR WHICH ADVERTISED PERFORMING THESE PRENATAL SCREENING TESTS, ABOUT THE USE OF SUCH TEST FOR SCREENING PURPOSES, THE FACT THAT NOT ALL HIGH RISK OCCURRENCES CORRESPOND TO A POSITIVE RESULT, THE FACT THAT NOT ALL LOW RISK RESULTS CORRESPOND TO A NEGATIVE RESULT, A CLEAR STATEMENT INDICATING THAT NON-INVASIVE PRENATAL SCREENINGS ARE INTENDED SOLELY FOR SCREENING PURPOSES TO ASSESS RISK OF POSSIBLE FETAL GENETIC ABNORMALITIES AND IS NOT INTENDED TO BE USED FOR DIAGNOSTIC PURPOSES TO DETERMINE WHETHER SUCH ABNORMALITIES ACTUALLY EXIST AND THAT EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.